Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) Patients between the age group of 18-60 years of either sex. b) Willing and able to participate in the study for 90 days. c) Patients having Serum Cholesterol 201-400mg/dl, Serum Triglycerides 151- 400 mg/dI LDL Cholesterol 131-250 mg/dl, HDL Details Cholesterol d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%)
Exclusion criteria
Exclusion criteria: 1) Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure ,Stroke or severe Arrhythmia, Unstable angina in the last six months. 2) Patients on prolonged ( >6weeks) medication with corticosteroids, antidepressants, anti cholinergics, immunosuppressant 3) Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents. 4)Patients with uncontrolled diabetes mellitus and HbA1C >7% 5) Patients with evidence of malignancy. 6)Hypersensitivity to any of the trial drugs or their ingredients. 7)Patients who have completed participation in any other clinical trial drugs or their ingredients in one month 8)Patients who have received any cholesterol lowering medication (allopathic drug) within last two weeks. 9)Pregnancy and Lactating mother. .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid Profile-total cholesterol, LDL-C, HDL-C, Triglycerides Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| A detailed evaluation of biochemical investigations(Hemogram ,RBS,Urine- routine and microscopic examination.,Kidney Function tests,Liver function tests will be repeated at the end of the study.) Timepoint: 3 months | — |
Countries
India
Contacts
A and U Tibbia College & Hospital